We are the first to investigate longer-term effects of pharmacological treatment of ADHD on children's health. We rely on a difference-in-differences strategy while exploiting Danish register-based panel data for children born in 1990-1999. We study effects of treatment initiated between ages...

We investigate the spillover effects of early-life medical treatments on the siblings of treated children. We use a regression discontinuity design that exploits changes in medical treatments across the very low birth weight (VLBW) cutoff. Using administrative data from Denmark, we first confirm...

It is notoriously difficult to identify peer effects within the family, because of the common shocks and reflection problems. We make use of a novel identification strategy and unique data in order to gain some purchase on this problem. We employ data from the universe of children born in...

It is notoriously difficult to identify peer effects within the family, because of the common shocks and reflection problems. We make use of a novel identification strategy and unique data in order to gain some purchase on this problem. We employ data from the universe of children born in...

This paper estimates effects of early ADHD medication use on key human capital outcomes for children diagnosed with ADHD while using rarely available register based data on diagnoses and prescription drug purchases. Our main identification strategy exploits plausible exogenous assignment of...

We employ a large social experiment combined with register-based data allowing for up to 12-year follow-up to evaluate a long-lasting employer-sponsored health and well-being program. We show that employees at treated worksites receive fewer consultations from their primary care physician and...